Background Insulin resistance, dyslipidaemia and abnormal nonesterified fat
ty acid (NEFA) metabolism are features of the 'metabolic syndrome', but the
mechanisms of these relationships are uncertain.
Materials and methods We studied associations between insulin resistance an
d lipoprotein concentrations by retrospective analysis of euglycaemic hyper
insulinaemic clamp data from 867 normoglycaemic subjects in 21 European cen
tres. Data on NEFA concentrations were available in a subgroup of 541 subje
cts from 9 clinical centres. These subjects' characteristics do not vary si
gnificantly from those of the whole cohort.
Results After adjustment for the effects of age, sex, obesity and intercent
re variability, regression analysis showed relationships between triglyceri
des and markers of insulin sensitivity. There were significant correlations
between triglycerides and fasting plasma glucose (P < 0.0001), fasting pla
sma insulin (P < 0.0001) and mean glucose infusion rate at steady state (M-
value, P < 0.0001). Indices of insulin resistance were related to NEFA conc
entrations. Fasting NEFA were negatively correlated with the M-value (P < 0
.0001). Non-esterified fatty acids at steady state were positively correlat
ed with fasting markers of insulin resistance: fasting plasma glucose (P <
0.05), fasting plasma insulin (P < 0.005) and negatively correlated with th
e M-value (P < 0.0005). There were relationships between fasting concentrat
ions of plasma lipids and of NEFAs. Non-esterified fatty acids at steady st
ate correlated with fasting triglycerides (P < 0.0001), but not with any of
the other plasma lipoprotein concentrations. The associations of fasting t
riglycerides with the M-value and with NEFAs at steady state were independe
nt of each other. All these associations were independent of obesity and ge
ographical location
Conclusion The results in this large cohort of healthy European subjects su
ggest that triglyceride concentrations depend upon both insulin's gluco-reg
ulation (estimated by glucose uptake) and antilipolytic insulin action (mea
sured by NEFA levels) during an euglycaemic clamp.